Phio Pharmaceuticals Corp.
USD1.02
+0.04 (+4.06%)
CEO
Robert L. Bitterman
IPO Date
2012-05-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.02
Prev. Close
$0.98
Day Low
$1.01
Day High
$1.05
52W Low
$0.81
52W High
$4.19
Market Cap
$0.01B
Volume
0.22M
| -0.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -140.1% | -115.6% | 0.00 | 5.71 | -0.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -105.9% | -89.6% | 0.02 | 6.42 | -0.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -60.6% | -52.8% | 0.01 | 8.06 | -1.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -67.6% | -55.9% | 0.05 | 6.91 | -1.4 |
| 31 Dec 2019 | FY | 100.0% | -42419.0% | -155.0% | -110.8% | 0.09 | 3.88 | -0.5 |
| 31 Dec 2018 | FY | -3034.8% | -5333.3% | -54.2% | -48.0% | 0.00 | 8.69 | -0.3 |
| 31 Dec 2017 | FY | -35700.0% | -83013.3% | -679.3% | -303.9% | 0.00 | 1.69 | -1.0 |
| 31 Dec 2016 | FY | -28400.0% | -47336.8% | -82.9% | -67.1% | 0.00 | 5.16 | -0.5 |
| -1.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -24.3% | -20.8% | 0.00 | 22.27 | -1.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -21.5% | -19.2% | 0.00 | 9.36 | -1.3 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -14.5% | -13.2% | 0.00 | 10.58 | -0.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -34.4% | -28.3% | 0.00 | 5.65 | -0.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -30.8% | -26.0% | 0.00 | 6.38 | -0.6 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -48.9% | -34.9% | 0.00 | 3.47 | -0.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -38.4% | -31.4% | 0.00 | 5.48 | -0.4 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -24.5% | -20.2% | 0.00 | 5.71 | -0.4 |